TickerFactsScreenerDevelopers

NEOGENOMICS INC (NEO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $916.0K2011: $897.0K2012: $2.62M2013: $2.01M2014: $3.77M2015: $2.21M2016: $7.54M2017: $13.69M2018: $14.31M2019: $20.03M2020: $29.10M2021: $64.14M2022: $30.89M2023: $28.75M2024: $41.06M2025: $27.01M$27.01M
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$27.01M-34.2%
2024$41.06M+42.8%
2023$28.75M-6.9%
2022$30.89M-51.8%
2021$64.14M+120.4%
2020$29.10M+45.3%
2019$20.03M+40.0%
2018$14.31M+4.5%
2017$13.69M+81.7%
2016$7.54M+240.2%
2015$2.21M-41.3%
2014$3.77M+87.6%
2013$2.01M-23.1%
2012$2.62M+191.5%
2011$897.0K-2.1%
2010$916.0K—